{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:58:28Z","timestamp":1771487908981,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1007\/s11926-006-0016-4","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T11:14:46Z","timestamp":1180782886000},"page":"317-322","source":"Crossref","is-referenced-by-count":15,"title":["Neuro-beh\u00e7et\u2019s syndrome: Differential diagnosis and management"],"prefix":"10.1007","volume":"8","author":[{"given":"Erdal","family":"Diri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis R.","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"16_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/kei257","volume":"45","author":"CG Barnes","year":"2006","unstructured":"Barnes CG: Treatment of Behcet\u2019s syndrome. Rheumatology 2006, 45:245\u2013247. Article reviews general aspects and therapy of Beh\u00e7et\u2019s syndrome well.","journal-title":"Rheumatology"},{"key":"16_CR2","unstructured":"Uber rezidivierende aphthose durch ein virus verursachte Beh\u00e7et H. geschwure am mund, am auge und an den genitalien [in German]. Dermatol Wochenschr 1937, 105:1152\u20131157."},{"key":"16_CR3","first-page":"2393","volume":"29","author":"R Tunc","year":"2002","unstructured":"Tunc R, Keyman E, Melikoglu M, et al.: Target organ associations in Turkish patients with Behcet\u2019s disease: a cross sectional study by exploratory factor analysis. J Rheumatol 2002, 29:2393\u20132396.","journal-title":"J Rheumatol"},{"key":"16_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0002-9343(01)01081-6","volume":"112","author":"H Yazici","year":"2002","unstructured":"Yazici H: Behcet\u2019s syndrome: Where do we stand? Am J Med 2002, 112:75\u201376. An editorial from an expert in the area of Beh\u00e7et\u2019s syndrome.","journal-title":"Am J Med"},{"key":"16_CR5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1136\/ard.60.11.1074","volume":"60","author":"E Diri","year":"2001","unstructured":"Diri E, Mat C, Hamuryudan V, et al.: Papulopustular skin lesions are seen more frequently in patients with Behcet\u2019s syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 2001, 60:1074\u20131076.","journal-title":"Ann Rheum Dis"},{"key":"16_CR6","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G: Behcet\u2019s disease. N Engl J Med 1999, 341:1284\u20131291.","journal-title":"N Engl J Med"},{"key":"16_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(98)80001-2","volume":"27","author":"VG Kaklamani","year":"1998","unstructured":"Kaklamani VG, Vaiopoulos G, Kaklamanis PG: Behcet\u2019s disease. Semin Arthritis Rheum 1998, 27:197\u2013217.","journal-title":"Semin Arthritis Rheum"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/bjo.87.7.876","volume":"87","author":"W Poon","year":"2003","unstructured":"Poon W, Verity DH, Larkin GL, et al.: Behcet\u2019s disease in patients of west African and Afro-Caribbean origin. Br J Ophthalmol 2003, 87:876\u2013878.","journal-title":"Br J Ophthalmol"},{"key":"16_CR9","first-page":"820","volume":"15","author":"S Yurdakul","year":"1988","unstructured":"Yurdakul S, Gunaydin I, Tuzun Y, et al.: The prevalence of Behcet\u2019s syndrome in a rural area in northern Turkey. J Rheumatol 1988, 15:820\u2013822.","journal-title":"J Rheumatol"},{"key":"16_CR10","first-page":"145","volume-title":"Beh\u00e7et\u2019s disease.","author":"K Nakae","year":"1993","unstructured":"Nakae K, Masaki F, Hashimoto T, et al.: Recent epidemiological features of Beh\u00e7et\u2019s disease in Japan. In: Beh\u00e7et\u2019s disease. Edited by Wechsler B, Godeau P. Amsterdam: Excerpta Medica; 1993:145\u2013151."},{"key":"16_CR11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H, Tuzun Y, Pararli H, et al.: Influence of age of onset and patient\u2019s sex on the prevalence and severity of manifestations of Behcet\u2019s syndrome. Ann Rheum Dis 1984, 43:783\u2013789.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 38","key":"16_CR12","first-page":"S96","volume":"23","author":"P Fietta","year":"2005","unstructured":"Fietta P: Behcet\u2019s disease: familial clustering and immunogenetics. Clin Exp Rheumatol 2005, 23(Suppl 38):S96-S105. This very comprehensive and detailed article reviews the immunogenetics of Beh\u00e7et\u2019s syndrome.","journal-title":"Clin Exp Rheumatol"},{"key":"16_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.43.1.74","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H, Chamberlain MA, Tuzun Y, et al.: A comparative study of the pathergy reaction among Turkish and British patients with Behcet\u2019s disease. Ann Rheum Dis 1984, 43:74\u201375.","journal-title":"Ann Rheum Dis"},{"key":"16_CR14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/08820530500231953","volume":"20","author":"AA Bonfioli","year":"2005","unstructured":"Bonfioli AA, Orefice F: Behcet\u2019s disease. Semin Ophthalmol 2005, 20:199\u2013206.","journal-title":"Semin Ophthalmol"},{"key":"16_CR15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1191\/0961203305lu2208oa","volume":"14","author":"F Atzeni","year":"2005","unstructured":"Atzeni F, Sarzi-Puttini P, Doria A, et al.: Behcet\u2019s disease and cardiovascular involvement. Lupus 2005, 14:723\u2013726. Article contains an in-depth review of the cardiovascular involvement in Beh\u00e7et\u2019s syndrome, as well as the authors\u2019 own related clinical experience.","journal-title":"Lupus"},{"key":"16_CR16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/40.2.212","volume":"40","author":"M Melikoglu","year":"2001","unstructured":"Melikoglu M, Altiparmak MR, Fresko I, et al.: A reappraisal of amyloidosis in Behcet\u2019s syndrome. Rheumatology 2001, 40:212\u2013215.","journal-title":"Rheumatology"},{"key":"16_CR17","doi-asserted-by":"crossref","unstructured":"International Study Group for Behcet\u2019s Disease: Criteria for diagnosis of Behcet\u2019s disease. Lancet 1990, 335:1078-1080.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"16_CR18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.nrl.0000156343.16797.c4","volume":"11","author":"Haghighi A Borhani","year":"2005","unstructured":"Borhani Haghighi A, Pourmand R, Nikseresht AR: Neuro-Behcet disease: a review. Neurologist 2005, 11:80\u201389. The authors provide a comprehensive overview of neuro-Beh\u00e7et\u2019s syndrome.","journal-title":"Neurologist"},{"key":"16_CR19","first-page":"91","volume":"17","author":"RL Chin","year":"2005","unstructured":"Chin RL, Latov N: Central nervous system manifestations of rheumatologic diseases. Curr Opin Rheumatol 2005, 17:91\u201399. This paper has a good discussion of the differential diagnosis of rheumatic disorders causing central nervous system manifestations.","journal-title":"Curr Opin Rheumatol"},{"key":"16_CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneur.1989.00520390031011","volume":"46","author":"P Serdaroglu","year":"1989","unstructured":"Serdaroglu P, Yazici H, Ozdemir C, et al.: Neurologic involvement in Behcet\u2019s syndrome: a prospective study. Arch Neurol 1989, 46:265\u2013269.","journal-title":"Arch Neurol"},{"key":"16_CR21","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir G, Serdaroglu P, Tasci B: Clinical patterns of neurological involvement in Behcet\u2019s disease: evaluation of 200 patients. The Neuro-Behcet Study Group. Brain 1999, 122:2171\u20132182. This excellent report describes in detail the neurological manifestations in a large population of patients with Beh\u00e7et\u2019s. Prognostic factors are also discussed.","journal-title":"Brain"},{"key":"16_CR22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0046-8177(85)80250-1","volume":"16","author":"S Lakhanpal","year":"1985","unstructured":"Lakhanpal S, Tani K, Lie JT, et al.: Pathologic features of Behcet\u2019s syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985, 16:790\u2013795.","journal-title":"Hum Pathol"},{"key":"16_CR23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/ard.61.7.655","volume":"61","author":"I Kone-Paut","year":"2002","unstructured":"Kone-Paut I, Gorchakoff-Molinas A, Weschler B, Touitou I: Paediatric Behcet\u2019s disease in France [letter]. Ann Rheum Dis 2002, 61:655\u2013656.","journal-title":"Ann Rheum Dis"},{"key":"16_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarci OH, Saip S, et al.: Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95\u2013103. This is a well-designed study describing the frequencies of the different neurologic manifestations of Beh\u00e7et\u2019s syndrome.","journal-title":"J Neurol"},{"key":"16_CR25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/01.WNL.0000130192.12100.8D","volume":"63","author":"SM Mirsattari","year":"2004","unstructured":"Mirsattari SM, McGinn GJ, Halliday WC: Neuro-Behcet disease with predominant involvement of the brainstem. Neurology 2004, 63:382\u2013384.","journal-title":"Neurology"},{"key":"16_CR26","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/brain\/122.11.2183","volume":"122","author":"D Kidd","year":"1999","unstructured":"Kidd D, Steuer A, Denman AM, Rudge P: Neurological complications in Behcet\u2019s syndrome. Brain 1999, 122:2183\u20132194.","journal-title":"Brain"},{"key":"16_CR27","first-page":"238","volume":"145","author":"LE Davis","year":"1986","unstructured":"Davis LE, Hodgin UG, Kornfeld M: Recurrent meningoencephalitis with recovery from Behcet\u2019s disease. West J Med 1986, 145:238\u2013239.","journal-title":"West J Med"},{"key":"16_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1468-2982.2005.01017.x","volume":"26","author":"E Aykutlu","year":"2006","unstructured":"Aykutlu E, Baykan B, Akman-Demir G, et al.: Headache in Behcet\u2019s disease. Cephalalgia 2006, 26:180\u2013186.","journal-title":"Cephalalgia"},{"key":"16_CR29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1212\/WNL.42.3.614","volume":"42","author":"B Wechsler","year":"1992","unstructured":"Wechsler B, Vidailhet M, Piette JC, et al.: Cerebral venous thrombosis in Behcet\u2019s disease: clinical study and long-term follow-up of 25 cases. Neurology 1992, 42:614\u2013618.","journal-title":"Neurology"},{"key":"16_CR30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.clineuro.2004.07.002","volume":"107","author":"CL Ho","year":"2005","unstructured":"Ho CL, Deruytter MJ: Manifestations of Neuro-Behcet\u2019s disease: report of two cases and review of the literature. Clin Neurol Neurosurg 2005, 107:310\u2013314.","journal-title":"Clin Neurol Neurosurg"},{"key":"16_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/anr.1780320217","volume":"32","author":"JD Zelenski","year":"1989","unstructured":"Zelenski JD, Capraro JA, Holden D, Calabrese LH: Central nervous system vasculitis in Behcet\u2019s syndrome: angiographic improvement after therapy with cytotoxic agents. Arthritis Rheum 1989, 32:217\u2013220.","journal-title":"Arthritis Rheum"},{"key":"16_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00029330-200603010-00017","volume":"119","author":"ZH Dong","year":"2006","unstructured":"Dong ZH, Fu WG, Guo DQ, et al.: Endovascular repair for a huge vertebral artery pseudoaneurysm caused by Behcet\u2019s disease. Chin Med J 2006, 119:435\u2013437.","journal-title":"Chin Med J"},{"key":"16_CR33","first-page":"1665","volume-title":"Rheumatology.","author":"H Yazici","year":"2003","unstructured":"Yazici H, Yurdakul S, Hamuryudan V, Fresko I: Beh\u00e7et\u2019s syndrome. In Rheumatology. Edited by Hochberg MC, Silman AJ, Smolen JS, et al.: Madrid, Spain: Mosby; 2003:1665\u20131669."},{"key":"16_CR34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0404.2005.00414.x","volume":"112","author":"D Reske","year":"2005","unstructured":"Reske D, Petereit HF, Heiss WD: Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system-value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis. Acta Neurol Scand 2005, 112:207\u2013213. Article describes a good study of the value of cerebrospinal fluid analysis in the differential diagnosis of immunologic conditions affecting the central nervous system.","journal-title":"Acta Neurol Scand"},{"key":"16_CR35","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1212\/WNL.41.9.1398","volume":"41","author":"MB Sharief","year":"1991","unstructured":"Sharief MB, Hentges R, Thomas E: Significance of CSF immunoglobulins in monitoring neurologic disease activity in Behcet\u2019s disease. Neurology 1991, 41:1398\u20131401.","journal-title":"Neurology"},{"key":"16_CR36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jneuroim.2003.08.040","volume":"145","author":"G Saruhan-Direskeneli","year":"2003","unstructured":"Saruhan-Direskeneli G, Yentur SP, Akman-Demir G, et al.:Cytokines and chemokines in neuro-Behcet\u2019s disease compared to multiple sclerosis and other neurological diseases. J Neuroimmunol 2003, 145:127\u2013134.","journal-title":"J Neuroimmunol"},{"key":"16_CR37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00234-003-1102-1","volume":"45","author":"G Akman-Demir","year":"2003","unstructured":"Akman-Demir G, Bahar S, Coban O, et al.: Cranial MRI in Behcet\u2019s disease: 134 examinations of 98 patients. Neuroradiology 2003, 45:851\u2013859. Article reports in detail the cranial MRI findings of neuro-Beh\u00e7et\u2019s syndrome.","journal-title":"Neuroradiology"},{"key":"16_CR38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jbspin.2005.01.012","volume":"73","author":"H Erdem","year":"2006","unstructured":"Erdem H, Dinc A, Pay S, et al.: A neuro-Behcet\u2019s case complicated with intracranial hypertension successfully treated by a lumboperitoneal shunt. Joint Bone Spine 2006, 73:200\u2013201.","journal-title":"Joint Bone Spine"},{"key":"16_CR39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/jnnp.43.3.210","volume":"43","author":"S Motomura","year":"1980","unstructured":"Motomura S, Tabira T, Kuroiwa Y: A clinical comparative study of multiple sclerosis and neuro-Behcet\u2019s syndrome. J Neurol Neurosurg Psychiatry 1980, 43:210\u2013213.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"16_CR40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/jnnp.58.5.548","volume":"58","author":"BN McLean","year":"1995","unstructured":"McLean BN, Miller D, Thompson EJ: Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behcet\u2019s disease involving the nervous system. J Neurol Neurosurg Psychiatry 1995, 58:548\u2013554.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"16_CR41","first-page":"1408","volume":"26","author":"E Diri","year":"1999","unstructured":"Diri E, Espinoza CG, Espinoza LR: Spinal cord granulomatous vasculitis: an unusual clinical presentation of sarcoidosis. J Rheumatol 1999, 26:1408\u20131410.","journal-title":"J Rheumatol"},{"key":"16_CR42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","volume":"248","author":"A Siva","year":"2001","unstructured":"Siva A, Kantarcy OH, Saip S, et al.: Behcet\u2019s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol 2001, 248:95\u2013103.","journal-title":"J Neurol"},{"key":"16_CR43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11940-000-0042-x","volume":"2","author":"A Siva","year":"2000","unstructured":"Siva A, Fresko I I: Behcet\u2019s disease. Curr Treat Options Neurol 2000, 2:435\u2013448.","journal-title":"Curr Treat Options Neurol"},{"key":"16_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0002-9343(84)90753-8","volume":"76","author":"JD O\u2019Duffy","year":"1984","unstructured":"O\u2019Duffy JD, Robertson DM, Goldstein NP: Chlorambucil in the treatment of uveitis and meningoencephalitis of Behcet\u2019s disease. Am J Med 1984, 76:75\u201384.","journal-title":"Am J Med"},{"key":"16_CR45","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.1986.tb05753.x","volume":"115","author":"CG Ranselaar","year":"1986","unstructured":"Ranselaar CG, Boone RM, Kluin-Nelemans HC: Thalidomide in the treatment of neuro-Behcet\u2019s syndrome. Br J Dermatol 1986, 115:367\u2013370.","journal-title":"Br J Dermatol"},{"key":"16_CR46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/ard.62.5.492","volume":"62","author":"M Calguneri","year":"2003","unstructured":"Calguneri M, Ozturk MA, Ertenli I, et al.: Effects of interferon alpha treatment on the clinical course of refractory Behcet\u2019s disease: an open study. Ann Rheum Dis 2003, 62:492\u2013493.","journal-title":"Ann Rheum Dis"},{"key":"16_CR47","first-page":"181","volume":"32","author":"H Sarwar","year":"2005","unstructured":"Sarwar H, McGrath H, Jr, Espinoza LR: Successful treatment of long-standing neuro-Behcet\u2019s disease with infliximab. J Rheumatol 2005, 32:181\u2013183.","journal-title":"J Rheumatol"},{"key":"16_CR48","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/jnnp.2004.055434","volume":"76","author":"C Ribi","year":"2005","unstructured":"Ribi C, Sztajzel R, Delavelle J, Chizzolini C: Efficacy of TNF alpha blockade in cyclophosphamide resistant neuro-Behcet disease. J Neurol Neurosurg Psychiatry 2005, 76:1733\u20131735.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"16_CR49","first-page":"555","volume":"150","author":"B Wechsler","year":"1999","unstructured":"Wechsler B, Gerber S, Vidailhet M, Dormont D: Neurologic manifestations of Behcet\u2019s disease [in French]. Ann Med Interne 1999, 150:555\u2013561.","journal-title":"Ann Med Interne"},{"key":"16_CR50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-510X(98)00165-8","volume":"159","author":"S Hirohata","year":"1998","unstructured":"Hirohata S, Suda H, Hashimoto T: Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet\u2019s disease. J Neurol Sci 1998, 159:181\u2013185.","journal-title":"J Neurol Sci"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-006-0016-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-006-0016-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-006-0016-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:22:39Z","timestamp":1683865359000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-006-0016-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["16"],"URL":"https:\/\/doi.org\/10.1007\/s11926-006-0016-4","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}